Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-Iodine for Pleurodesis via Tunneled Pleural Catheters
NCT02975921Phase 4Withdrawn
- Sponsor
- Yale University
- Start
- Jul 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of povidone-iodine in pleural effusion (4 arms), sponsored by Yale University. Primary endpoint: Time to Tunneled Pleural Catheter Removal at 6 months. Planned start Jul 2018; status: withdrawn.
02
Drugs
povidone-iodine
03
Conditions
pleural effusion
Beyond the preview
Go deeper on NCT02975921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975921.